According to a recent article published in Current Opinion in Endocrinology, Diabetes, and Obesity by CM Schooling titled “Testosterone and cardiovascular disease.”, there is a clear link between use of testosterone supplements such as AndroGel and increased risk for heart attack.
Schooling (2014) writes, “Use of testosterone among men is increasing rapidly. Low serum testosterone is positively associated with cardiovascular disease and its risk factors” and explains that the article aims to review current literature regarding testosterone and adverse cardiac event.
“In a large, well conducted pharmacoepidemiology study specifically testosterone prescription was associated with myocardial infarction.” (For clarity, “myocardial infarction” means heart attack.)
“A comprehensive meta-analysis of RCTs summarizing 27 trials including 2994 men found increased risk of cardiovascular-related events on testosterone (odds ratio 1.54, 95% confidence interval 1.09-2.18).” This means that men using testosterone therapy products such as AndroGel are 54% more likely to suffer “cardiovascular-related events” than non-users.
Because the manufacturers of AndroGel (AbbVie, Inc., Abbott Laboratories, Inc.) have failed time and again to adequately warn users of the risk for heart attack, stroke, and other adverse cardiac events, a number of AndroGel lawsuits are currently being filed. If you or someone you know used AndroGel and suffered a heart attack or other cardiovascular side effect, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of AndroGel lawyers at the information provided below. We have the experience, resources, and skills required to win the justice you deserve.
(855) 452 – 5529